Thomas S. Lam - 05 Mar 2026 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Role
Director
Signature
/s/ Kathy Diep, as Attorney-in-Fact
Issuer symbol
ASTH
Transactions as of
05 Mar 2026
Net transactions value
$0
Form type
4
Filing time
09 Mar 2026, 16:16:36 UTC
Previous filing
10 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lam Thomas S. Director C/O ASTRANA HEALTH, INC., 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA /s/ Kathy Diep, as Attorney-in-Fact 09 Mar 2026 0001664499

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASTH Common Stock Tax liability -9,266 -2.1% $25.07* 423,990 05 Mar 2026 Direct F2, F3
holding ASTH Common Stock 6,132,802 05 Mar 2026 By Allied Physicians of California, a Professional Medical Corporation F1
holding ASTH Common Stock 1,133,706 05 Mar 2026 By the Thomas and Jeanette Lam 2002 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are beneficially owned by Allied Physicians of California, a Professional Medical Corporation, of which the Reporting Person is the Chief Executive Officer and Chief Financial Officer and a director and stockholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2 Represents the surrender of shares to offset against tax withholding obligations associated with shares of restricted stock that vested on March 5, 2026.
F3 Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 51,667 shares, which will vest in two equal annual installments beginning on March 5, 2027; and (ii) 26,667 shares, which will vest upon achievement of certain pre-established performance goals.